Transcriptional control of local estrogen formation by aromatase in the breast

Journal of Steroid Biochemistry and Molecular Biology

Volumn 145, Issue , 2015, Pages 179-186

  To, Sarah Q ^a,b   Knower, Kevin C ^a,b   Cheung, Vanessa ^a,b   Simpson, Evan R ^a,b   Clyne, Colin D ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aromatase; Aromatase inhibitors; Breast cancer; Estrogen

Indexed keywords

AROMATASE; ESTROGEN; CYP19A1 PROTEIN, HUMAN; ESTROGEN RECEPTOR;

BREAST TUMOR; CHROMOSOME 15; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ESTROGEN SYNTHESIS; HUMAN; HUMAN GENOME; HUMAN TISSUE; PROTEIN EXPRESSION; REVIEW; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; BREAST; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PROMOTER REGION; UDDER;

ANIMALS; AROMATASE; BREAST; BREAST NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC;

EID: 84915760302     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.05.004     Document Type: Review

References (141)

1. S.T. Pearce, and V.C. Jordan The biological role of estrogen receptors alpha and beta in cancer Crit. Rev. Oncol. Hematol. 50 1 2004 3 22
2. P. Pujol Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis Cancer Res. 58 23 1998 5367 5373
3. M. Campbell-Thompson, I.J. Lynch, and B. Bhardwaj Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer Cancer Res. 61 2 2001 632 640
4. G.G. Chen, Q. Zeng, and G.M. Tse Estrogen and its receptors in cancer Med. Res. Rev. 28 6 2008 954 974
5. S.E. Bulun Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment Pharmacol. Rev. 57 3 2005 359 383
6. D.L. Manning, L.H. Archibald, and K.T. Ow Cloning of estrogen-responsive messenger RNAs in the T-47D human breast cancer cell line Cancer Res. 50 13 1990 4098 4104
7. W.R. Miller Aromatase and the breast: regulation and clinical aspects Maturitas 54 4 2006 335 341
8. V.R. Agarwal Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients J. Clin. Endocrinol. Metab. 81 11 1996 3843 3849
9. G.S. Chetrite Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J. Steroid Biochem. Mol. Biol. 72 1-2 2000 23 27
10. Z. Huang Dual effects of weight and weight gain on breast cancer risk JAMA 278 17 1997 1407 1411
11. A.A. van Landeghem Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue Cancer Res. 45 6 1985 2900 2906
12. S.E. Bulun A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription J. Clin. Endocrinol. Metab. 77 6 1993 1622 1628
13. I. Czajka-Oraniec, and E.R. Simpson Aromatase research and its clinical significance Endokrynol. Pol. 61 1 2010 126 134
14. G.D. Means Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues Mol. Endocrinol. 5 12 1991 2005 2013
15. K. Toda Characterization of a cis-acting regulatory element involved in human-aromatase P-450 gene expression Eur. J. Biochem. 205 1 1992 303 309
16. H. Nawata Aromatase in bone cell: association with osteoporosis in postmenopausal women J. Steroid Biochem. Mol. Biol. 53 1-6 1995 165 174
17. C.K. Wagner, and J.I. Morrell Neuroanatomical distribution of aromatase MRNA in the rat brain: indications of regional regulation J. Steroid Biochem. Mol. Biol. 61 3-6 1997 307 314
18. G.D. Berkovitz, T. Bisat, and K.M. Carter Aromatase activity in microsomal preparations of human genital skin fibroblasts: influence of glucocorticoids J. Steroid Biochem. 33 3 1989 341 347
19. S.E. Bulun, and E.R. Simpson Breast cancer and expression of aromatase in breast adipose tissue Trends Endocrinol. Metab. 5 3 1994 113 120
20. J.M. Grodin, P.K. Siiteri, and P.C. MacDonald Source of estrogen production in postmenopausal women J. Clin. Endocrinol. Metab. 36 2 1973 207 214
21. S.E. Bulun, and E.R. Simpson Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks: thighs, and abdomen of women increase with advancing age J. Clin. Endocrinol. Metab. 78 2 1994 428 432
22. C.R. Durham Regulation of aromatase activity of rat granulosa cells: induction of synthesis of NADPH-cytochrome P-450 reductase by FSH and dibutyryl cyclic AMP Mol. Cell. Endocrinol. 40 2-3 1985 211 219
23. ThompsonF E.A. Jr.; and P.K. Siiteri The involvement of human placental microsomal cytochrome P-450 in aromatization J. Biol. Chem. 249 17 1974 5373 5378
24. M. Akhtar Mechanistic studies on C-19 demethylation in oestrogen biosynthesis Biochem. J. 201 3 1982 569 580
25. S. Honda Disruption of sexual behavior in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene Biochem. Biophys. Res. Commun. 252 2 1998 445 449
26. C.R. Fisher Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene Proc. Natl. Acad. Sci. U. S. A. 95 12 1998 6965 6970
27. K.M. Robertson Characterization of the fertility of male aromatase knockout mice J. Androl. 22 5 2001 825 830
28. M.E. Jones Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proc. Natl. Acad. Sci. U. S. A. 97 23 2000 12735 12740
29. O.K. Oz Bone has a sexually dimorphic response to aromatase deficiency J. Bone Miner. Res. 15 3 2000 507 514
30. M. Shozu A new cause of female pseudohermaphroditism: placental aromatase deficiency J. Clin. Endocrinol. Metab. 72 3 1991 560 566
31. Y. Ito Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries Proc. Natl. Acad. Sci. U. S. A. 90 24 1993 11673 11677
32. F.A. Conte A syndrome of female pseudohermaphrodism: hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom) J. Clin. Endocrinol. Metab. 78 6 1994 1287 1292
33. A. Morishima Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens J. Clin. Endocrinol. Metab. 80 12 1995 3689 3698
34. N. Verma Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency J. Pediatr. Endocrinol. Metab. 25 11-12 2012 1185 1190
35. E.K. Baykan Aromatase deficiency, a rare syndrome: case report J. Clin. Res. Pediatr. Endocrinol. 5 2 2013 129 132
36. C. Carani Effect of testosterone and estradiol in a man with aromatase deficiency N. Engl. J. Med. 337 2 1997 91 95
37. J. Deladoey Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy J. Clin. Endocrinol. Metab. 84 11 1999 4050 4054
38. L. Maffei Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment J. Clin. Endocrinol. Metab. 89 1 2004 61 70
39. G.D. Berkovitz Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids J. Clin. Invest. 75 6 1985 1763 1769
40. C.A. Stratakis The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription J. Clin. Endocrinol. Metab. 83 4 1998 1348 1357
41. R.M. Martin Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings J. Clin. Endocrinol. Metab. 88 7 2003 3027 3034
42. M. Shozu Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene N. Engl. J. Med. 348 19 2003 1855 1865
43. S.A. Chen Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15 DNA 7 1 1988 27 38
44. S. Sebastian, and S.E. Bulun A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project J. Clin. Endocrinol. Metab. 86 10 2001 4600 4602
45. M.S. Mahendroo, C.R. Mendelson, and E.R. Simpson Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue J. Biol. Chem. 268 26 1993 19463 19470
46. S. Sebastian Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue Mol. Endocrinol. 16 10 2002 2243 2254
47. Y. Zhao, C.R. Mendelson, and E.R. Simpson Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes Mol. Endocrinol. 9 3 1995 340 349
48. N. Irahara Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer Int. J. Cancer 118 8 2006 1915 1921
49. Y. Zhao Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter J. Biol. Chem. 270 27 1995 16449 16457
50. H. Odawara Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) alpha in breast cancer cells: identification of a novel ROR response element J. Biol. Chem. 284 26 2009 17711 17719
51. Y. Zhao Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4 Mol. Endocrinol. 10 11 1996 1350 1357
52. E.R. Simpson Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids Proc. Natl. Acad. Sci. U. S. A. 78 9 1981 5690 5694
53. M.J. Reed The effect of glucocorticoids on the in vivo conversion of androstenedione to oestrone Horm. Metab. Res. 18 9 1986 635 637
54. C. Longcope Peripheral aromatization: studies on controlling factors Steroids 50 1-3 1987 253 267
55. S. Bourguiba Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3′,5′-monosphosphate Biol. Reprod. 69 2 2003 592 601
56. S.A. Salama Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance J. Clin. Endocrinol. Metab. 94 1 2009 285 293
57. S. Carreau The promoter(s) of the aromatase gene in male testicular cells Reprod. Biol. 4 1 2004 23 34
58. J. Wilde Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor alpha J. Mol. Endocrinol. 51 2 2013 247 260
59. S.Q. To, K.C. Knower, C.D. Clyne, and N.FkappaB MAPK signalling pathways mediate TNFalpha-induced Early Growth Response gene transcription leading to aromatase expression Biochem. Biophys. Res. Commun. 433 1 2013 96 101
60. S.Q. To Involvement of early growth response factors in TNFalpha-induced aromatase expression in breast adipose Breast Cancer Res. Treat. 138 1 2013 193 203
61. K.C. Knower Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts Mol. Cell. Endocrinol. 321 2 2010 123 130
62. S.Q. To Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer J. Steroid Biochem. Mol. Biol. 132 3-5 2012 331 338
63. C. Jenkins Exon-specific northern analysis and rapid amplification of cDNA ends (RACE) reveal that the proximal promoter II (PII) is responsible for aromatase cytochrome P450 (CYP19) expression in human ovary Mol. Cell. Endocrinol. 97 1-2 1993 R1 R6
64. Y. Zhao Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture J. Steroid Biochem. Mol. Biol. 61 3-6 1997 203 210
65. Y. Zhao Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP: leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 12 1996 5739 5742
66. J.A. Richards, and R.W. Brueggemeier Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes J. Clin. Endocrinol. Metab. 88 6 2003 2810 2816
67. K. Subbaramaiah EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange J. Biol. Chem. 283 6 2008 3433 3444
68. M.A. Thorat Prostanoid receptor EP1 expression in breast cancer Mod. Pathol. 21 1 2008 15 21
69. J.W. Regan EP2 and EP4 prostanoid receptor signaling Life Sci. 74 2-3 2003 143 153
70. M. Sofi Role of CRE-binding protein (CREB) in aromatase expression in breast adipose Breast Cancer Res. Treat. 79 3 2003 399 407
71. K.A. Brown Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women Cancer Res. 69 13 2009 5392 5399
72. N.U. Samarajeewa CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes Horm. Cancer 4 4 2013 233 241
73. N.U.et al. Samarajeewa HIF-1alpha stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma Breast Cancer Res. 15 2 2013 R30
74. G.L. Rubin Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy Cancer Res. 60 6 2000 1604 1608
75. S. Catalano Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line: TM4 Mol. Endocrinol. 17 5 2003 923 934
76. S. Swami Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo Horm. Cancer 2 3 2011 190 202
77. M. Lanzino DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation Cell Death Dis. 4 2013 e724
78. K.C. Knower Distinct nuclear receptor expression in stroma adjacent to breast tumors Breast Cancer Res. Treat. 142 1 2013 211 223
79. A.L. Chand Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts Steroids 76 8 2011 741 744
80. C.D. Clyne Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes J. Biol. Chem. 277 23 2002 20591 20597
81. Y. Miki Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells Cancer Res. 67 8 2007 3945 3954
82. K.A. Lazarus Oestradiol reduces liver receptor homolog-1 mRNA transcript stability in breast cancer cell lines Biochem. Biophys. Res. Commun. 438 3 2013 533 539
83. R. Safi Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy Cancer Res. 65 24 2005 11762 11770
84. K.A. Lazarus Conditional over-expression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of transforming growth factor-beta Endocrinology 2014 p. en20131948
85. K.R. Holloway SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression Mol. Endocrinol. 27 3 2013 480 490
86. C. Yang, D. Zhou, and S. Chen Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor Cancer Res. 58 24 1998 5695 5700
87. A.L. Chand, E.R. Simpson, and C.D. Clyne Aromatase expression is increased in BRCA1 mutation carriers BMC Cancer 9 2009 148
88. S. Ghosh Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells Am. J. Physiol. Endocrinol. Metab. 292 1 2007 E246 E252
89. J.R. Prosperi, and F.M. Robertson Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells Prostaglandins Other Lipid Mediat. 81 1-2 2006 55 70
90. A.M. Brodie Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo Steroids 38 6 1981 693 702
91. D. Giudici 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor J. Steroid Biochem. Mol. Biol. 30 1-6 1988 391 394
92. H.J. Burstein American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer J. Clin. Oncol. 28 23 2010 3784 3796
93. P.E. Lonning, and H.P. Eikesdal Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved Endocr. Relat. Cancer 20 4 2013 R183 R201
94. S. Chumsri Aromatase, aromatase inhibitors, and breast cancer J. Steroid Biochem. Mol. Biol. 125 1-2 2011 13 22
95. A.H. Partridge Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer J. Clin. Oncol. 26 4 2008 556 562
96. S. Chumsri Advances in mechanisms of resistance to aromatase inhibitors Expert Rev. Anticancer Ther. 14 4 2014 381 393
97. M.P. Jansen Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer Cancer Res. 73 22 2013 6632 6641
98. G.J. Sabnis Functional activation of the estrogen receptor-alpha and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole Cancer Res. 71 5 2011 1893 1903
99. G.J. Sabnis HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2 Mol. Cancer Ther. 12 12 2013 2804 2816
100. C. Yang Regulation of aromatase promoter activity in human breast tissue by nuclear receptors Oncogene 21 18 2002 2854 2863
101. T. Okubo Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein: snail (SnaH) Cancer Res. 61 4 2001 1338 1346
102. A. Kovacic Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes Mol. Endocrinol. 18 1 2004 252 259
103. M. Lu BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells J. Clin. Endocrinol. Metab. 91 11 2006 4514 4519
104. S. Deb A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts J. Biol. Chem. 281 5 2006 2585 2597
105. R. Gao Methylseleninic acid is a novel suppressor of aromatase expression J. Endocrinol. 212 2 2012 199 205
106. S. Chen The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression Proc. Natl. Acad. Sci. U. S. A. 107 24 2010 11032 11037
107. W. Fan Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB Endocrinology 146 1 2005 85 92
108. G.L. Rubin Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose Endocrinology 143 8 2002 2863 2871
109. T. Yanase Regulation of aromatase by nuclear receptors J. Steroid Biochem. Mol. Biol. 79 1-5 2001 187 192
110. K. Subbaramaiah Pioglitazone, a PPARgamma agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1 Cancer Prev. Res. 5 10 2012 1183 1194
111. K. Subbaramaiah Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300 J. Biol. Chem. 276 15 2001 12440 12448
112. M. Monami, I. Dicembrini, and E. Mannucci Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials Acta Diabetol. 51 1 2014 91 101
113. A. Neumann Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study Diabetologia 55 7 2012 1953 1962
114. M. Cazzaniga Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol. Biomarkers Prev. 18 3 2009 701 705
115. J. Kim Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR) BMC Cancer 14 1 2014 170
116. K.A. Brown Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase Breast Cancer Res. Treat. 123 2 2010 591 596
117. N.U. Samarajeewa Promoter-specific effects of metformin on aromatase transcript expression Steroids 76 8 2011 768 771
118. S. Rice Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway Endocrinology 150 10 2009 4794 4801
119. I.P. Fuhrmeister Human granulosa cells: insulin and insulin-like growth factor-1 receptors and aromatase expression modulation by metformin Gynecol. Obstet. Invest. 77 3 2014 156 162
120. Y. Takemura Metformin suppresses interleukin (IL)-1beta-induced IL-8 production: aromatase activation, and proliferation of endometriotic stromal cells J. Clin. Endocrinol. Metab. 92 8 2007 3213 3218
121. S. Cos Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells Cancer Res. 58 19 1998 4383 4390
122. D.E. Blask, and S.M. Hill Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture J. Neural Transm. Suppl. 21 1986 433 449
123. M.M. Leon-Blanco Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro J. Pineal Res. 35 3 2003 204 211
124. C. Martinez-Campa Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen: cadmium J. Pineal Res. 40 4 2006 291 296
125. C.M. Martinez-Campa Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells Cancer Lett. 268 2 2008 272 277
126. S.T. Wilson, D.E. Blask, and A.M. Lemus-Wilson Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro J. Clin. Endocrinol. Metab. 75 2 1992 669 670
127. M.D. Mediavilla Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene J. Pineal Res. 22 2 1997 86 94
128. T.M. Molis Melatonin modulation of estrogen-regulated proteins: growth factors, and proto-oncogenes in human breast cancer J. Pineal Res. 18 2 1995 93 103
129. K.C. Knower Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts Breast Cancer Res. Treat. 132 2 2012 765 771
130. S. Cos Melatonin modulates aromatase activity in MCF-7 human breast cancer cells J. Pineal Res. 38 2 2005 136 142
131. S. Cos Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity Int. J. Cancer 118 2 2006 274 278
132. T. Kiefer Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells Breast Cancer Res. Treat. 71 1 2002 37 45
133. S.I. Khan Potential utility of natural products as regulators of breast cancer-associated aromatase promoters Reprod. Biol. Endocrinol. 9 2011 91
134. Y. Wang The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression Br. J. Nutr. 99 2 2008 303 310
135. L. Ye, M.Y. Chan, and L.K. Leung The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway Mol. Cell. Endocrinol. 302 1 2009 73 80
136. S. Rice, H.D. Mason, and S.A. Whitehead Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells J. Steroid Biochem. Mol. Biol. 101 4-5 2006 216 225
137. J.T. Sanderson Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells Toxicol. Sci. 82 1 2004 70 79
138. J.T. Kellis Jr.; and L.E. Vickery Inhibition of human estrogen synthetase (aromatase) by flavones Science 225 4666 1984 1032 1034
139. L. Ye Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase Int. J. Cancer 124 5 2009 1028 1036
140. I. Kijima Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression Cancer Res. 66 11 2006 5960 5967
141. Y. Wang The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells Toxicol. Sci. 92 1 2006 71 77